NGM Biopharmaceuticals: Q4 Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — NGM Biopharmaceuticals Inc. (NGM) on Tuesday reported a loss of $36.4 million...
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — NGM Biopharmaceuticals Inc. (NGM) on Tuesday reported a loss of $36.4 million in its fourth quarter. On a per-share basis, the South San Francisco, California-based company said it had a loss of 45 cents. The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 52 cents per share. The biotechnology company posted revenue of $18.2 million in the period, which also topped Street forecasts.